期刊
JOURNAL OF VASCULAR RESEARCH
卷 47, 期 1, 页码 69-79出版社
KARGER
DOI: 10.1159/000235927
关键词
Caveolin-1; PPAR gamma; Macrophages; Atherosclerosis
资金
- National 973 Basic Research Program of China [2006CB503803]
- National Hi-tech Research and Development Program of China [2006AA02A406]
- National Natural Science Foundation of China [30470701, 30570747, 30670873]
- Provincial Science-Tech Development Program of Shandong [2008GG30002021]
Objective: Caveolin-1 (Cav-1) may positively or negatively influence the development of atherosclerosis, depending on the cell type and the metabolic pathways regulated by this protein. We investigate the effects of Cav-1 on cholesterol efflux in RAW264.7 infected with AdPPAR gamma 1 and whether Cav-1 could attenuate established atherosclerotic lesions in PPAR gamma 1-treated apoE-deficient mice. Methods and Results: Compared with AdGFP control, PPAR gamma 1 and Cav-1 were constitutively overexpressed in AdPPAR gamma 1-infected RAW264.7 cells, which stimulated cholesterol efflux to apolipoprotein A-I. Using a small interfering RNA approach (Cav-1-siRNA) we achieved an efficient and specific knockdown of caveolin-1 expression (80%), which resulted in a remarkable reduction of cholesterol efflux in RAW264.7 cells. Moreover, PPAR gamma 1-treated Cav-1-siRNA RAW264.7 cells showed more ability to stimulate cholesterol efflux than Cav-1-siRNA RAW264.7 cells, but far less than control-siRNA RAW264.7 cells and PPAR gamma 1-treated RAW264.7 cells. In addition, 40-week-old apoE-deficient mice fed a Western-type diet and infected for 4 weeks with AdPPAR gamma 1 showed induced Cav-1 expression in aortic vascular endothelial cells, smooth muscle cells and macrophages, as well as attenuated established atherosclerotic lesions. Conclusions: PPAR gamma 1 gene therapy could induce Cav-1 expression and enhance cholesterol efflux and attenuate atherosclerosis in apoE-deficient mice. Copyright (C) 2009 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据